These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 24154931)

  • 1. State parity laws and access to treatment for substance use disorder in the United States: implications for federal parity legislation.
    Wen H; Cummings JR; Hockenberry JM; Gaydos LM; Druss BG
    JAMA Psychiatry; 2013 Dec; 70(12):1355-62. PubMed ID: 24154931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Medicaid Acceptance by Substance Abuse Treatment Facilities After Implementation of Federal Parity.
    Geissler KH; Evans EA
    Med Care; 2020 Feb; 58(2):101-107. PubMed ID: 31688556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The United States' Federal Parity Act and treatment of substance use disorders: Administrators' familiarity and perceptions of impact.
    Edmond MB; Aletraris L; Roman PM; Fields DL; Bride BE
    Int J Drug Policy; 2016 Aug; 34():80-7. PubMed ID: 27450320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insurance expansions and adolescent use of substance use disorder treatment.
    Hamersma S; Maclean JC
    Health Serv Res; 2021 Apr; 56(2):256-267. PubMed ID: 33210305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Race/ethnicity and geographic access to Medicaid substance use disorder treatment facilities in the United States.
    Cummings JR; Wen H; Ko M; Druss BG
    JAMA Psychiatry; 2014 Feb; 71(2):190-6. PubMed ID: 24369387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Litigation Provides Clues to Ongoing Challenges in Implementing Insurance Parity.
    Berry KN; Huskamp HA; Goldman HH; Rutkow L; Barry CL
    J Health Polit Policy Law; 2017 Dec; 42(6):1065-1098. PubMed ID: 28801470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit requirements for substance use disorder treatment in state health insurance exchanges.
    Tran Smith B; Seaton K; Andrews C; Grogan CM; Abraham A; Pollack H; Friedmann P; Humphreys K
    Am J Drug Alcohol Abuse; 2018; 44(4):426-430. PubMed ID: 29261341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insurance barriers to substance use disorder treatment after passage of mental health and addiction parity laws and the affordable care act: A qualitative analysis.
    Dickson-Gomez J; Weeks M; Green D; Boutouis S; Galletly C; Christenson E
    Drug Alcohol Depend Rep; 2022 Jun; 3():100051. PubMed ID: 36845978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Oregon's parity law can tell us about the federal Mental Health Parity and Addiction Equity Act and spending on substance abuse treatment services.
    McConnell KJ; Ridgely MS; McCarty D
    Drug Alcohol Depend; 2012 Aug; 124(3):340-6. PubMed ID: 22382046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of federal parity on substance use disorder treatment.
    Busch SH; Epstein AJ; Harhay MO; Fiellin DA; Un H; Leader D; Barry CL
    Am J Manag Care; 2014; 20(1):76-82. PubMed ID: 24512166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral health insurance parity: does Oregon's experience presage the national experience with the Mental Health Parity and Addiction Equity Act?
    McConnell KJ; Gast SH; Ridgely MS; Wallace N; Jacuzzi N; Rieckmann T; McFarland BH; McCarty D
    Am J Psychiatry; 2012 Jan; 169(1):31-8. PubMed ID: 21890792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insurance Receipt and Readiness for Opportunities under the Affordable Care Act: A National Survey of Treatment Providers for Substance Use Disorders.
    Aletraris L; Edmond MB; Roman PM
    J Psychoactive Drugs; 2017; 49(2):141-150. PubMed ID: 28406363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Mental Health Parity and Addiction Equity Act (MHPAEA) evaluation study: Did parity differentially affect substance use disorder and mental health benefits offered by behavioral healthcare carve-out and carve-in plans?
    Friedman SA; Azocar F; Xu H; Ettner SL
    Drug Alcohol Depend; 2018 Sep; 190():151-158. PubMed ID: 30032052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Legislations and policies to expand mental health and substance abuse benefits in health insurance plans: a community guide systematic economic review.
    Jacob V; Qu S; Chattopadhyay S; Sipe TA; Knopf JA; Goetzel RZ; Finnie R; Thota AB;
    J Ment Health Policy Econ; 2015 Mar; 18(1):39-48. PubMed ID: 25862203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What Does Mental Health Parity Really Mean for the Care of People with Serious Mental Illness?
    Bartlett J; Manderscheid R
    Psychiatr Clin North Am; 2016 Jun; 39(2):331-42. PubMed ID: 27216906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental health parity legislation, cost-sharing and substance-abuse treatment admissions.
    Dave D; Mukerjee S
    Health Econ; 2011 Feb; 20(2):161-83. PubMed ID: 20029912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parity and out-of-pocket spending for children with high mental health or substance abuse expenditures.
    Barry CL; Chien AT; Normand SL; Busch AB; Azzone V; Goldman HH; Huskamp HA
    Pediatrics; 2013 Mar; 131(3):e903-11. PubMed ID: 23420919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coverage mandates and market dynamics: employer, insurer and patient responses to parity laws.
    Nathenson RA
    Health Econ Policy Law; 2020 Apr; 15(2):173-195. PubMed ID: 30309399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classifying substance use disorder treatment facilities with co-located mental health services: A latent class analysis approach.
    Mauro PM; Furr-Holden CD; Strain EC; Crum RM; Mojtabai R
    Drug Alcohol Depend; 2016 Jun; 163():108-15. PubMed ID: 27106113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Federal Parity and Access to Behavioral Health Care in Private Health Plans.
    Hodgkin D; Horgan CM; Stewart MT; Quinn AE; Creedon TB; Reif S; Garnick DW
    Psychiatr Serv; 2018 Apr; 69(4):396-402. PubMed ID: 29334882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.